Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer

Head and Neck

Volumn 36, Issue 2, 2014, Pages 291-298

  Batth, Sukhjeet S ^a   Caudell, Jimmy J ^b   Chen, Allen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

dosimetry; dysphagia; head and neck cancer; IMRT; swallowing dysfunction

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ASPIRATION PNEUMONIA; CANCER RECURRENCE; DOSIMETRY; DYSPHAGIA; ENTERIC FEEDING; ESOPHAGUS STENOSIS; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; NECK DISSECTION; NUTRITIONAL STATUS; ORGANS AT RISK; OROPHARYNX CANCER; PAROTID GLAND; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; REVIEW; STOMACH TUBE; SWALLOWING; XEROSTOMIA;

DOSIMETRY; DYSPHAGIA; HEAD AND NECK CANCER; IMRT; SWALLOWING DYSFUNCTION;

CHEMORADIOTHERAPY; DEGLUTITION DISORDERS; EVIDENCE-BASED MEDICINE; HEAD AND NECK NEOPLASMS; HUMANS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84892442219     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23246     Document Type: Review

References (52)

1. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098.
2. Nguyen NP, Sallah S, Karlsson U, Antoine JE,. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002; 94: 1131-1141.
3. Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 2004; 15: 383-388.
4. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, et al. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008; 26: 3770-3776.
5. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-136.
6. Caudell JJ, Schaner PE, Desmond RA, et al. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 76: 403-409.
7. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
8. Salama JK, Stenson KM, List MA, et al. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134: 1060-1065.
9. Lazarus CL,. Effects of chemoradiotherapy on voice and swallowing. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 172-178.
10. Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction: preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003; 57: 1219-1230.
11. Lee WT, Akst LM, Adelstein DJ, et al. Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck 2006; 28: 808-812.
12. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50: 1161-1171.
13. Rademaker AW, Pauloski BR, Logemann JA, Shanahan TK,. Oropharyngeal swallow efficiency as a representative measure of swallowing function. J Speech Hear Res 1994; 37: 314-325.
14. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL,. A penetration-aspiration scale. Dysphagia 1996; 11: 93-98.
15. Karnell MP, MacCracken E,. A database information storage and reporting system for videofluorographic oropharyngeal motility (OPM) swallowing evaluations. Am J Speech Lang Pathol 1994; 3: 54.
16. Cox JD, Stetz J, Pajak TF,. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
17. Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 1995; 31: 1043-1047.
18. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995; 31: 1049-1091.
19. NCI, NIH, DHHS. Common terminology criteria for adverse events v4.0. Bethesda, MD: National Cancer Institute; 2009.
20. Thomas L, Jones TM, Tandon S, et al. An evaluation of the University of Washington Quality of Life swallowing domain following oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008; 265 (Suppl 1): S29-S37.
21. Terrell JE, Nanavati KA, Esclamado RM, et al. Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg 1997; 123: 1125-1132.
22. Sherman AC, Simonton S, Adams DC, et al. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 2000; 126: 459-467.
23. Funk GF, Karnell LH, Christensen AJ, Moran PJ, Ricks J,. Comprehensive head and neck oncology health status assessment. Head Neck 2003; 25: 561-575.
24. Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127: 870-876.
25. List MA, D'Antonio LL, Cella DF, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer 1996; 77: 2294-2301.
26. McHorney CA, Robbins J, Lomax K, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III Documentation of reliability and validity. Dysphagia 2002; 17: 97-114.
27. Jensen K, Lambertsen K, Torkov P, et al. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol 2007; 46: 1159-1168.
28. Caudell JJ, Schaner PE, Meredith RF, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009; 73: 410-415.
29. Langendijk JA, Doornaert P, Rietveld DHF, et al. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 2009; 90: 189-195.
30. Werbrouck J, De Ruyck K, Duprez F, et al. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 2009; 73: 1187-1195.
31. Truong MT, Lee R, Saito N, et al. Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome. Int J Radiat Oncol Biol Phys 2012; 82: e119-e127.
32. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439.
33. Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 1110-1118.
34. Li B, Li D, Lau DH, et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 2009; 4: 52.
35. Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007; 68: 750-757.
36. Bhide SA, Gulliford S, Kazi R, et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 2009; 93: 539-544.
37. Eisbruch A, Kim HM, Feng FY, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011; 81: e93-e99.
38. Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78: 1356-1365.
39. Dabaja B, Salehpour MR, Rosen I, et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 2005; 63: 1000-1005.
40. Fua TF, Corry J, Milner AD, et al. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys 2007; 67: 976-981.
41. Galloway TJ, Amdur RJ, Liu C, Yeung AR, Mendenhall WM,. Revisiting unnecessary larynx irradiation with whole-neck IMRT. Pract Radiat Oncol 2011; 1: 27-32.
42. Caudell JJ, Burnett OL, Schaner PE, Bonner JA, Duan J,. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys 2010; 77: 462-467.
43. Webster GJ, Rowbottom CG, Ho KF, Slevin NJ, Mackay RI,. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck. Int J Radiat Oncol Biol Phys 2008; 72: 617-622.
44. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007; 85: 64-73.
45. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-1298.
46. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010; 28: 2732-2738.
47. Peponi E, Glanzmann C, Willi B, Huber G, Studer G,. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol 2011; 6: 1.
48. Langerman A, MacCracken E, Kasza K, et al. Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1289-1295.
49. Teguh DN, Levendag PC, Sewnaik A, et al. Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx. Radiother Oncol 2008; 89: 57-63.
50. Teguh DN, Levendag PC, Noever I, et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 2008; 72: 1119-1127.
51. Christianen ME, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP,. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol 2011; 101: 394-402.
52. Vineberg KA, Eisbruch A, Feng M,. Consequences of pharyngeal constrictor contouring method on dose calculation and optimization. In: ASTRO 52nd Annual Meeting, San Diego, CA; 2010.